ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Optometrist

Top Optometrist Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SPENCER MOY OD

Optometrist

7,789

$891K

1759
1688 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 67%

$114
Average prescription price

Avg: $107

ESTELA OGISTE MD, PHD

Optometrist

6,587

$536K

1065
914 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 67%

$81
Average prescription price

Avg: $107

EUGENE ORLOFF OD

Optometrist

4,306

$587K

629
585 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

83%
prescriptions for brand name drugs

Avg: 67%

$136
Average prescription price

Avg: $107

ALEXANDER KABIRI O.D.

Optometrist

3,725

$615K

656
547 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

76%
prescriptions for brand name drugs

Avg: 67%

$165
Average prescription price

Avg: $107

GENA KOCHIN OD

Optometrist

3,502

$556K

551
522 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

92%
prescriptions for brand name drugs

Avg: 67%

$159
Average prescription price

Avg: $107

ELENA FELDMAN OD

Optometrist

3,427

$477K

618
573 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

89%
prescriptions for brand name drugs

Avg: 67%

$139
Average prescription price

Avg: $107

CHARLES GOLD

Optometrist

3,357

$611K

533
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

96%
prescriptions for brand name drugs

Avg: 67%

$182
Average prescription price

Avg: $107

JAMESINA CHIM O.D.

Optometrist

2,966

$398K

627
585 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

87%
prescriptions for brand name drugs

Avg: 67%

$134
Average prescription price

Avg: $107

ARTHUR VAYNER O.D.

Optometrist

2,910

$355K

496
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

88%
prescriptions for brand name drugs

Avg: 67%

$122
Average prescription price

Avg: $107

SHARON WILLIAMS O.D.

Optometrist

2,377

$640K

464
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

95%
prescriptions for brand name drugs

Avg: 67%

$269
Average prescription price

Avg: $107

ALEXANDER TARNARIDER O.D.

Optometrist

2,276

$214K

468
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 67%

$94
Average prescription price

Avg: $107

GALINA KRUGLYAKOVA OD

Optometrist

2,260

$219K

268
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 67%

$97
Average prescription price

Avg: $107

ADELINA VOLIS OD

Optometrist

2,104

$253K

378
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

86%
prescriptions for brand name drugs

Avg: 67%

$120
Average prescription price

Avg: $107

ROSTISLAV RYVKIN O.D.

Optometrist

1,954

$207K

458
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

87%
prescriptions for brand name drugs

Avg: 67%

$106
Average prescription price

Avg: $107

RACHELLE GOLLER O.D.

Optometrist

1,924

$228K

358
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

93%
prescriptions for brand name drugs

Avg: 67%

$118
Average prescription price

Avg: $107

BORIS KAPELNIK O.D.

Optometrist

1,887

$303K

372
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

92%
prescriptions for brand name drugs

Avg: 67%

$160
Average prescription price

Avg: $107

KARENA WONG O.D.

Optometrist

1,720

$120K

364
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 67%

$70
Average prescription price

Avg: $107

AMY CHEN O.D.

Optometrist

1,660

$230K

327
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

78%
prescriptions for brand name drugs

Avg: 67%

$139
Average prescription price

Avg: $107

JULIA ALEXANDROV O.D.

Optometrist

1,652

$176K

306
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

86%
prescriptions for brand name drugs

Avg: 67%

$106
Average prescription price

Avg: $107

MARTIN AVILES O.D

Optometrist

1,623

$149K

242
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 67%

$92
Average prescription price

Avg: $107

LILY CHIN OD

Optometrist

1,617

$195K

571
542 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

81%
prescriptions for brand name drugs

Avg: 67%

$121
Average prescription price

Avg: $107

DAVID YIP O.D.

Optometrist

1,550

$162K

368
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

87%
prescriptions for brand name drugs

Avg: 67%

$105
Average prescription price

Avg: $107

ADOLPHUS ANOSIKE O,D.

Optometrist

1,527

$154K

454
375 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 67%

$101
Average prescription price

Avg: $107

NATALYA MALAKOVA O.D.

Optometrist

1,468

$175K

242
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 67%

$119
Average prescription price

Avg: $107

SARAH KLEIN OD

Optometrist

1,467

$118K

231
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 67%

$81
Average prescription price

Avg: $107

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank